PharmaLex

pharmalex.com · Bonn, Germany

PharmaLex is a global provider of specialized consulting and outsourced services for the pharmaceutical, biotech, and medical device industries, focusing on regulatory affairs, pharmacovigilance, quality management, and market access. The company supports clients across the product lifecycle, from development and registration through post‑marketing compliance, by providing expert advisory and managed services. It generates revenue through project-based consulting engagements and long-term outsourcing contracts with life sciences companies and sponsors.

Revenue
$450.0M
Employees
3,000
Founded
2012
Headquarters
Bonn, Germany

What 30 Arbolus experts think of PharmaLex

NPS distribution shows 60% Promoters (NPS 9–10), 38% Passives (NPS 7–8), and 2% Detractors (NPS 0–6). Renewal intent is strongly positive among high spend and long-term clients; new and pilot users show more uncertainty. Stickiness is high with over 70% in production for more than a year. The most common themes are satisfaction with reliability, compliance assurance, and scalability. Overall Customer Sentiment: Positive

Who reviewed PharmaLex

Total customers 30 27 current · 3 former
Reviews growth +9 in six months
Seniority of respondents
  • C-Suite 57% (17)
  • Director 33% (10)
  • Manager 10% (3)
Revenue Leader C-Suite NPS 9 Will renew
Operations Ops C-Suite NPS 10 Will renew
Legal Analyst Manager NPS 8

Employer names and spend open once the report publishes.

Tell us when the PharmaLex report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

36 Net Promoter Score, from 30 scored reviews
  • Promoters 13
  • Passives 15
  • Detractors 2

Cumulative NPS by month

+0 over 6 months
  • Dec 8
  • Jan 8
  • Jun 8
  • Jul 8
  • Aug 8
  • Sep 8

Net Promoter Score across 3 reviews, accumulated up to each month. Category median 36 across 3 companies.

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 64%
  • Will renew 16
  • Undecided 8
  • Not renewing 1

Plan to renew, by seniority

  • C-Suite 56% 16 answers
  • Director 71% 7 answers
  • Manager 100% 2 answers
  • 8.6/10 Average score from customers who will renew
  • 7.1/10 Average score from undecided customers
  • 9/10 Average score from customers not renewing

Top alternatives

Most weighed by PharmaLex customers

For people who use PharmaLex

Do you use PharmaLex at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 30 customers of PharmaLex have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.